The Patent Finder
RA

Runway Advisors, LLC

First filing 2007
OverviewNotableFeesChangesFamiliesPatent listSources & methods

6 patents currently held

9 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in May 2030. from the record

Of the 9 now held by other companies, 9 name Hikma Pharmaceuticals USA Inc. as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
3
Ending by 2030
May 2030
Next term end
4
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents fee due within 90 days all others Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Formerly held, still cited

Notable
The most cited patent in this portfolio, cited by 173 later US patents, top 5% of utility patents granted in 2011 in our data. Protection runs to 2028.
Ends May 2028 · High confidence
Also notable
Cited by 68 later US patents, top 10% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2033.
Ends Jan 2033 · Medium confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 16, 2027
    The maintenance fee for Methods and Compositions for Treating Herpes (US 10,350,288) comes due Jan 16, 2027. Unpaid by Jul 16, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 3 largest of its 4 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 6 of 6

PatentTitleStatusExpiresConfidence
US 9,895,436Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response
In force
 · High confidence
In forceHigh confidence
US 10,653,771Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US 8,617,564Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response
In force
 · High confidence
In forceHigh confidence
US 9,782,474Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response
In force
 · High confidence
In forceHigh confidence
US 9,624,273Nucleic Acid Vaccines Against Herpes Simplex Virus Type 2: Compositions and Methods for Eliciting an Immune Response
In force
 · High confidence
In forceHigh confidence
US 10,350,288Methods and Compositions for Treating Herpes
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
Also on record, not counted in the 6: 9 patents in force now held by others · 30 patents ended. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited